In this study we used mouse models of cachexia to test the hypothesis that cancer cahexia may be associated with changes in tumour glucose metabolism, and that targeting Fn14 signalling in tumour, which is associated with body weight loss, can alter the [18F]FDG tumour uptake. Here, TNFRSF12A is linked to cancer.